Anixa Biosciences Inc (ANIX)

Anixa Biosciences (ANIX) Financial Statements


Anixa Biosciences Financial Overview

Anixa Biosciences's market cap is currently ―. The company's EPS TTM is $-0.316; its P/E ratio is -11.08; Anixa Biosciences is scheduled to report earnings on March 8, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Oct 23Jul 23Apr 23Jan 23Oct 22
Income Statement-
Total Revenue--$ 210.00K-$ 0.00
Gross Profit$ 5.40M$ -2.84M$ 210.00K$ 2.56M$ 0.00
EBIT$ -2.72M$ -2.55M$ 3.23M$ -2.56M$ -3.61M
EBITDA$ -2.71M$ -2.54M$ 3.25M$ -2.54M$ -3.60M
Net Income Common Stockholders$ -2.69M$ -2.51M$ 3.21M$ -2.32M$ -3.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.84M$ 25.53M$ 26.98M$ 27.70M$ 29.69M
Total Assets$ 25.52M$ 26.58M$ 27.60M$ 28.31M$ 30.41M
Total Debt$ 175.00K$ 187.00K$ 198.00K$ 209.00K$ 221.00K
Net Debt$ -23.67M$ -25.35M$ -26.78M$ -27.49M$ -29.47M
Total Liabilities$ 2.15M$ 1.99M$ 1.69M$ 1.39M$ 2.21M
Stockholders Equity$ 24.34M$ 25.52M$ 26.81M$ 27.79M$ 29.05M
Cash Flow-
Free Cash Flow$ -1.97M$ -1.45M$ -807.00K$ -1.99M$ -1.59M
Operating Cash Flow$ -1.97M$ -1.45M$ -807.00K$ -1.99M$ -1.59M
Investing Cash Flow$ -593.00K$ -980.00K$ -3.44M$ -585.00K$ -9.92M
Financing Cash Flow$ 279.00K$ 3.00K$ 81.00K$ 3.00K$ -384.00K
Currency in USD

Anixa Biosciences Earnings and Revenue History

Anixa Biosciences Debt to Assets

Anixa Biosciences Cash Flow

Anixa Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis